Cargando…
Neuroprotection in early stages of Alzheimer’s disease is promoted by transthyretin angiogenic properties
BACKGROUND: While still controversial, it has been demonstrated that vascular defects can precede the onset of other AD hallmarks features, making it an important therapeutic target. Given that the protein transthyretin (TTR) has been established as neuroprotective in AD, here we investigated the in...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385857/ https://www.ncbi.nlm.nih.gov/pubmed/34429155 http://dx.doi.org/10.1186/s13195-021-00883-8 |